Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
Applications Due:
Closed
Federal
US Department of Health & Human Services (National Institutes of Health)
This grant provides funding for researchers to explore how HIV and substance use disorders affect protein interactions in microglia, aiming to uncover mechanisms that could lead to new treatments for these interconnected conditions.
Description
The goal of this funding opportunity announcement is to generate brain region and cell-type specific microglial protein profiles in the context of HIV and SUD, then use those molecular profiles and interaction networks to establish mechanisms of how HIV-harboring microglia may contribute specifically to neuropathologies encountered with comorbid HIV and SUD.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Native American tribal organizations, Nonprofits
Funding
Program Funding
Award Ceiling
Award Floor
Award Count
Timing
Posted Date
July 19, 2023
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
NIH Grants Information
Contact Email
Contact Phone
--